Stella Dracheva

Dr. Stella Dracheva


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AKAlexey Kozlenkov
Alexey Kozlenkov
PRPanos Roussos
Panos Roussos
ATAlisa Timashpolsky
Alisa Timashpolsky
MBMihaela Barbu
Mihaela Barbu
SRSergei Rudchenko
Sergei Rudchenko
SDStella Dracheva
Stella Dracheva
We applied Illumina Human Methylation450K array to perform a genomic-scale single-site resolution DNA methylation analysis in neuronal and nonneuronal (primarily glial) nuclei separated from the orbitofrontal cortex of postmortem human brain. The findings were validated using enhanced reduced representation bisulfite sequencing. We identified thousands of sites differentially methylated (DM) between neuronal and nonneuronal cells. The DM sites were depleted within CpG-island–containing promoters but enriched in predicted enhancers. Classification of the DM sites into those undermethylated in neurons (neuronal type) and those undermethylated in nonneuronal cells (glial type), combined with findings of others that methylation within control elements typically negatively correlates with gene expression, yielded large sets of predicted neuron-specific and non–neuron-specific genes. These sets of predicted genes were in excellent agreement with the available direct measurements of gene expression in human and mouse. We also found a distinct set of DNA methylation patterns that were unique for neuronal cells. In particular, neuronal-type differential methylation was overrepresented in CpG island shores, enriched within gene bodies but not in intergenic regions, and preferentially harbored binding motifs for a distinct set of transcription factors, including neuron-specific activity-dependent factors. Finally, non-CpG methylation was substantially more prevalent in neurons than in nonneuronal cells.

7 September 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
AKAlexey Kozlenkov
Alexey Kozlenkov
JLJunhao Li
Junhao Li
PAPasha Apontes
Pasha Apontes
YHYasmin L. Hurd
Yasmin L. Hurd
WBWilliam M. Byne
William M. Byne
SDStella Dracheva
Stella Dracheva
DNA hydroxymethylation is a distinctive epigenetic regulator of human inhibitory neurons, potentially affecting brain diseases.

26 November 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
AKAlexey Kozlenkov
Alexey Kozlenkov
MWMinghui Wang
Minghui Wang
PRPanos Roussos
Panos Roussos
SRSergei Rudchenko
Sergei Rudchenko
MBMihaela Barbu
Mihaela Barbu
SDStella Dracheva
Stella Dracheva
The brain is built from a large number of cell types which have been historically classified using location, morphology and molecular markers. Recent research suggests an important role of epigenetics in shaping and maintaining cell identity in the brain. To elucidate the role of DNA methylation in neuronal differentiation, we developed a new protocol for separation of nuclei from the two major populations of human prefrontal cortex neurons—GABAergic interneurons and glutamatergic (GLU) projection neurons. Major differences between the neuronal subtypes were revealed in CpG, non-CpG and hydroxymethylation (hCpG). A dramatically greater number of undermethylated CpG sites in GLU versus GABA neurons were identified. These differences did not directly translate into differences in gene expression and did not stem from the differences in hCpG methylation, as more hCpG methylation was detected in GLU versus GABA neurons. Notably, a comparable number of undermethylated non-CpG sites were identified in GLU and GABA neurons, and non-CpG methylation was a better predictor of subtype-specific gene expression compared to CpG methylation. Regions that are differentially methylated in GABA and GLU neurons were significantly enriched for schizophrenia risk loci. Collectively, our findings suggest that functional differences between neuronal subtypes are linked to their epigenetic specification.

15 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJunhao Li
Junhao Li
MJManoj K. Jaiswal
Manoj K. Jaiswal
JCJo-Fan Chien
Jo-Fan Chien
AKAlexey Kozlenkov
Alexey Kozlenkov
JJJinyoung Jung
Jinyoung Jung
SDStella Dracheva
Stella Dracheva
A repeat expansion in the C9orf72 (C9) gene is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we investigate single nucleus transcriptomics (snRNA-seq) and epigenomics (snATAC-seq) in postmortem motor and frontal cortices from C9-ALS, C9-FTD, and control donors. C9-ALS donors present pervasive alterations of gene expression with concordant changes in chromatin accessibility and histone modifications. The greatest alterations occur in upper and deep layer excitatory neurons, as well as in astrocytes. In neurons, the changes imply an increase in proteostasis, metabolism, and protein expression pathways, alongside a decrease in neuronal function. In astrocytes, the alterations suggest activation and structural remodeling. Conversely, C9-FTD donors have fewer high-quality neuronal nuclei in the frontal cortex and numerous gene expression changes in glial cells. These findings highlight a context-dependent molecular disruption in C9-ALS and C9-FTD, indicating unique effects across cell types, brain regions, and diseases.

11 September 2007 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
SDStella Dracheva
Stella Dracheva
NPN Patel
N Patel
DWD A Woo
D A Woo
SMS M Marcus
S M Marcus
LSL J Siever
L J Siever
VHV Haroutunian
V Haroutunian
Suicide is a major public health problem with ∼ 1 million victims each year worldwide. Up to 90% of adults who commit suicide have at least one psychiatric diagnosis such as major depression, bipolar disorder (BPD), schizophrenia (SZ), substance abuse or dependence. A question that has remained unanswered is whether the biological substrates of suicide are distinct from those of the psychiatric disorders in which it occurs. The serotonin 2C receptor (5-HT2CR) has been implicated in depression and suicide. We, therefore, compared the frequencies of its mRNA editing variants in postmortem prefrontal cortical specimens from subjects who committed suicide or who died from other causes. All suicides occurred in the context of either SZ or BPD. The non-suicide cases included subjects with either SZ or BPD as well as subjects with no psychiatric diagnosis. We identified 5-HT2CR mRNA editing variations that were associated with suicide but not with the comorbid psychiatric diagnoses, and were not influenced by demographic characteristics (age and sex) and alcohol or drug use. These variations consisted of a significant increase in the pool of mRNA variants (ACD and ABCD) that encode one of the most prevalent and highly edited isoforms of 5-HT2CR, that is, VSV (Val156–Ser158–Val160). Because the VSV isoform of 5-HT2CR exhibits low functional activity, an increase in its expression frequency may significantly influence the serotonergic regulation of the brain. Thus, at least in patients with SZ or BPD, overexpression of the VSV isoform in the prefrontal cortex may represent an additional risk factor for suicidal behavior.

9 March 2012 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
PDF file
RLRebecca Lyddon
Rebecca Lyddon
ADAndrew J. Dwork
Andrew J. Dwork
MKMehdi Keddache
Mehdi Keddache
LSLarry J. Siever
Larry J. Siever
SDStella Dracheva
Stella Dracheva
Objectives. mRNA for serotonin 2C receptor (5-HT2CR) undergoes editing which results in numerous isoforms. More highly edited isoforms exhibit decreased function. We recently found greater 5-HT2CR editing in suicide victims with prior bipolar disorder (BPD) or schizophrenia (SZ) compared with non-suicide patients and normal controls (NC). This study compares suicides and non-suicides with major depressive disorder (MDDSuic and MDDNoSuic) and non-suicide NC. Methods. mRNA editing was assessed in prefrontal cortex of 24 MDDSuic, 21 MDDNoSuic, and 56 NC using next generation sequencing. mRNA expression of 5-HT2CR and editing enzymes (ADAR1-2) was assessed by real-time PCR. Results. Editing was lower in MDDNoSuic than in MDDSuic, which did not differ from NC. No differences in the 5-HT2CR or ADAR1 expression were detected. ADAR2 expression was higher in NC than in MDD subjects, but did not differ between MDDNoSuic and MDDSuic. Conclusions. Our findings suggest the presence of two factors associated with 5-HT2CR editing. One factor, which probably stems from decreased ADAR2 expression, is linked to MDD and is associated with less editing. The other, seen also in our previous study of suicide in BP and SZ, is linked to suicide alone and is associated with more editing and, therefore, less receptor function.